A woman lights a joint as a group of cannabis advocates smoke marijuana and march down Broad Street toward the Wells Fargo Center on the final day of the Democratic National Convention in Philadelphia, July 28, 2016. REUTERS/Dominick Reuter
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
People with psychiatric disorders may want to pass on the joint -- at least until further research is done, a new Australian study suggests.The paper, published Monday in The Lancet Psychiatry, looked at 83 previous studies conducted over almost four decades on medical cannabinoids, including products from the cannabis plant, such as leaves, buds and oils, as well as pharmaceutical-grade cannabinoids.Some studies showed improvement in anxiety symptoms, but it was unclear if that effect was due to improvements in the primary condition.In one small study of patients with psychosis, pharmaceutical THC -- the active substance in cannabis -- actually worsened symptoms.
FOLLOW THIS ARTICLE